and is divided into four lobes of unequal size and shape. The liver lies on the right side of the abdominal
cavity beneath the diaphragm.
Laboratory assessment of the patient with suspected or clinically obvious symptom of liver problem
is context-dependent. For instance, the acutely ill jaundiced patient with a history of prolonged
alcohol ingestion requires a different laboratory assessment than the well patient in whom one or
more standard tests for symptom of liver problem are discovered to be abnormal during routine
testing. Additionally, the sequence of tests for symptom of liver problem depends heavily on the
question asked. If the question is: Does this well person whose brother was recently diagnosed with
hemochromatosis also have this genetic disease?, then a series of tests will be initiated to detect
iron overload. When the question is: Has this spouse been infected with hepatitis B?, then blood
tests related to hepatitis B will be required. For these reasons, algorithms for evaluation of liver
disease need to be considered skeptically.
This site is designed to discuss a useful way of thinking about liver tests. It emphasizes limitations
of and alternative explanations for isolated abnormalities of common liver tests. Information in this
chapter should be combined with discussions of specific liver diseases elsewhere in this Disease
Management Project. A final caveat relates to terminology. Tests done in clinical laboratories do not
measure any functional capacity of the liver.
The diagnosis of liver diseases depends upon a combination of history, physical examination,
laboratory testing and sometimes radiological studies and biopsy. Only a physician who knows all of
these aspects of a specific case can reliably make a diagnosis. Many individuals with liver diseases
nonetheless have questions about their laboratory test results and seek information about their
significance. The purpose of this page is to briefly describe some of the common laboratory tests that
may be abnormal in individuals with liver diseases. Patients reading this page must keep in mind that
abnormalities of these laboratory tests are not diagnostic of specific diseases and that only a qualified
physician who knows the entire case can provide a reliable diagnosis.
Alanine aminotransferase (ALT)
ALT is an enzyme produced in hepatocytes, the major cell type in the liver. ALT is often inaccurately
referred to as a liver function test, however, its level in the blood tells little about the function of the
liver. The level of ALT in the blood (actually enzyme activity is measured in the clinical laboratory) is
increased in conditions in which hepatocytes are damaged or die. As cells are damaged, ALT leaks out
into the bloodstream. All types of hepatitis (viral, alcoholic, drug-induced, etc.) cause hepatocyte
damage that can lead to elevations in the serum ALT activity. The ALT level is also increased in cases of
liver cell death resulting from other causes, such as shock or drug toxicity. The level of ALT may
correlate roughly with the degree of cell death or inflammation, however, this is not always the case.
An accurate estimate of inflammatory activity or the amount cell death can only be made by liver
biopsy. (See also aspartate aminotransferase below.)
Aspartate aminotransferase (AST)
AST is an enzyme similar to ALT (see above) but less specific for liver disease as it is also produced in
muscle and can be elevated in other conditions (for example, early in the course of a heart attack).
AST is also inaccurately referred to as a liver function test by many physicians. In many cases of liver
inflammation, the ALT and AST activities are elevated roughly in a 1:1 ratio. In some conditions, such as
alcoholic hepatitis or shock liver, the elevation in the serum AST level may higher than the elevation in
the serum ALT level.
Alkaline phosphatase
Alkaline phosphatase is an enzyme, or more precisely a family of related enzymes, produced in the bile
ducts, intestine, kidney, placenta and bone. An elevation in the level of serum alkaline phosphatase
(actually enzyme activity is measured in the clinical laboratory), especially in the setting of normal or
only modestly elevated ALT and AST activities, suggests disease of the bile ducts. Serum alkaline
phosphatase activity can be markedly elevated in bile duct obstruction or in bile duct diseases such as
primary biliary cirrhosis or primary sclerosing cholangitis. Alkaline phosphatase is also produced in bone
and blood activity can also be increased in some bone disorders.
Gamma-glutamyltranspeptidase (GGT)
An enzyme produced in the bile ducts that, like alkaline phosphatase, may be elevated in the serum of
patients with bile duct diseases. Elevations in serum GGT, especially along with elevations in alkaline
phosphatase, suggest bile duct disease. Measurement of GGT is an extremely sensitive test, however,
and it may be elevated in virtually any liver disease and even sometimes in normal individuals. GGT is also
induced by many drugs, including alcohol, and its serum activity may be increased in heavy drinkers
even in the absence of liver damage or inflammation.
Bilirubin
Bilirubin is the major breakdown product that results from the destruction of old red blood cells (as
well as some other sources). It is removed from the blood by the liver, chemically modified by a process
call conjugation, secreted into the bile, passed into the intestine and to some extent reabsorbed from
the intestine. Bilirubin concentrations are elevated in the blood either by increased production,
decreased uptake by the liver, decreased conjugation, decreased secretion from the liver or blockage
of the bile ducts. In cases of increased production, decreased liver uptake or decreased conjugation,
the unconjugated or so-called indirect bilirubin will be primarily elevated. In cases of decreased
secretion from the liver or bile duct obstruction, the conjugated or so-called direct bilirubin will be
primarily elevated. Many different liver diseases, as well as conditions other than liver diseases (e. g.
increased production by enhanced red blood cell destruction), can cause the serum bilirubin
concentration to be elevated. Most adult acquired liver diseases cause impairment in bilirubin
secretion from liver cells that cause the direct bilirubin to be elevated in the blood. In chronic,
acquired liver diseases, the serum bilirubin concentration is usually normal until a significant amount of
liver damage has occurred and cirrhosis is present. In acute liver disease, the bilirubin is usually
increased relative to the severity of the acute process. In bile duct obstruction, or diseases of the bile
ducts such as primary biliary cirrhosis or sclerosing cholangitis, the alkaline phosphatase and GGT
activities are often elevated along with the direct bilirubin concentration.
Albumin
Albumin is the major protein that circulates in the bloodstream. Albumin is synthesized by the liver and
secreted into the blood. Low serum albumin concentrations indicate poor liver function. The serum
albumin concentration is usually normal in chronic liver diseases until cirrhosis and significant liver
damage is present. Albumin levels can be low in conditions other than liver diseases including
malnutrition, some kidney diseases and other rarer conditions.
Prothrombin time (PT)
Many factors necessary for blood clotting are made in the liver. When liver function is severely
abnormal, their synthesis and secretion into the blood is decreased. The prothrombin time is a type of
blood clotting test performed in the laboratory and it is prolonged when the blood concentrations of
some of the clotting factors made by the liver are low. In chronic liver diseases, the prothrombin time
is usually not elevated until cirrhosis is present and the liver damage is fairly significant. In acute liver
diseases, the prothrombin time can be prolonged with severe liver damage and return to normal as the
patient recovers. Prothrombin time can also be prolonged in cases of vitamin K deficiency, by drugs
(warfarin, used therapeutically as an anti-coagulant, prolongs the prothrombin time) and in non-liver
disorders.
Platelet count
Platelets are the smallest of the blood cells (actually fragments of larger cells known as
megakaryocytes) that are involved in clotting. In some individuals with liver disease, the spleen becomes
enlarged as blood flow through the liver is impeded. This can lead to platelets being sequestered in the
enlarged spleen. In chronic liver diseases, the platelet count usually falls only after cirrhosis has
developed. The platelet count can be abnormal in many conditions other than liver diseases.
Serum protein electrophoresis
In this test, the major proteins in the serum are separated in an electric field and their concentrations
determined. The four major types of serum proteins whose concentrations are measured in this test
are albumin, alpha-globulins, beta-globulins and gamma-globulins. Serum protein electrophoresis is a
useful test in patients with liver diseases as it can provide clues to several diagnostic possibilities. In
cirrhosis, the albumin may be decreased (see above) and the gamma-globulin elevated. Gamma-globulin
can be significantly elevated in some types of autoimmune hepatitis. The alpha-globulins can be low in
alpha-1-antitrypsin deficiency.
medgrip.com is a purely informational website, and should not be used as a substitute for professional medical help
The liver is the largest glandular organ of the body. It weighs about 3 lb (1.36 kg). It is reddish brown in color and is divided into four lobes of unequal size and shape. The liver lies on the right side of the abdominal cavity beneath the diaphrag